Molecule Signs Supply Agreement with ABcann what do we think about this?
OTTAWA, ON, Nov. 26, 2020 /CNW/ - Molecule Holdings Inc. (CSE: MLCL) ("Molecule" or the "Company"), a Canadian craft-focused cannabis beverage production company, is pleased to announce that it has signed a cannabis supply agreement with ABcann Medicinals Inc. ("ABcann" or the "Supplier"), a wholly owned subsidiary of Vivo Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO"), enabling Molecule to use Vertosa emulsions for use in its cannabis beverages.
ABcann has territory rights to Vertosa emulsion technology and generates the products on site. Vertosa's customized water-compatible solutions are reported to accelerate onset time, prolong shelf-life, increase bioavailability, and improve the taste profile of cannabis-infused products.
"We are excited to be working with Vertosa's emulsion tech and are impressed with their rigor and the test results we have seen. We are happy to be using this technology to infuse beverages and pleased to be working on this with Vivo," said Molecule CEO Phil Waddington.
"We are very pleased about the signing of this agreement with Molecule. We look forward to a long and mutually beneficial relationship with Molecule," said Michael Bumby, CFO of VIVO.